|
Gruber I.M., Egorova N.B., Kurbatova E.A., Mikhailova N.A.
Strategy for design of antistaphylococcal drugs for immunoprophylaxis and immunotherapy
|
№4 / 2013
|
|
Sundukov A.V., Gafurov Yu.T., Evsyukov O. A.
Clinical and laboratory features of abnormalities in the cervix uteri, external genitals, and vagina in HIV-infected patients
|
№4 / 2013
|
|
Shaginyan V.R., Gural A.L., Sergeeva T.A., Maksimenok E.V., Myshko O.V., Sadkova A.B.
The immunological and epidemiological efficiency of hepatitis B vaccination: Multicenter study results
|
№4 / 2013
|
|
Shandala M.G.
The place and role of disinfection in the prevention of human infectious diseases
|
№4 / 2013
|
|
Briko N.I.
Vaccination is a decisive measure to reduce the burden associated with infectious diseases among adults
|
№4 / 2013
|
|
Shkarin V.V., Kovalishena O.V.
An emerging infection monitoring and control system: Problems and prospects
|
№4 / 2013
|
|
Pokrovsky V.I.
V.V. Shkarin, O.V. Kovalishena. Emerging infections: Systematization, problems, prospects
|
№3 / 2013
|
|
Pyadushkina E.A., Andreeva N.S., Omelyanovsky V.V., Avxentyeva M.V., Rebrova O.Yu.
Сlinicoeconomic analysis of the use of kivexa in the first-line antiretroviral therapy of HIV infection in the Russian Federation
|
№3 / 2013
|
|
Konstantinov D.Yu., Konstantinova E.A., Popova L.L., Strebkova E.A., Suzdaltsev A.A.
New approaches to optimizing antiviral therapy in patients with chronic hepatitis C and low baseline leukocyte content
|
№3 / 2013
|
|
Ferrante S.A., Elbasha E.H.
Cost-Effectiveness Analysis of Boceprevir for the Treatment of Chronic Hepatitis C Virus Genotype 1 Infection in Russia
|
№3 / 2013
|
|
Kostinov M.P., Andreeva N.P., Petrova T.I.
Clinical and epidemiological efficiency of the prevention of pneumococcal infection with vaccine in infants
|
№3 / 2013
|
|
Pomogaeva A.P., Nosareva O.L., Zhavoronok T.V.
Lipid peroxidation and nonenzymatic antioxidative system in children with pseudotuberculosis
|
№3 / 2013
|
Русский
